PTEN and p53 Mutations in Endometrial Carcinomas

참고문헌 (30)

1. "Two pathogenetic types of endometrial carcinoma.", 15, pp.10~7 (1983)
2. "PTEN", MMAC1 mutationsin endometrial cancers., 1997, pp.57, 4736~4738
3. "Mutations in PTEN are frequentin endometrial carcinoma but rare in other common gynecologicalmalignancies.", 57, pp.3935~3940 (1997)
4. "Mutation of the PTEN tumor suppressor gene in endometrial hyperplasias.", 58, pp.2500~2503 (1998)
5. "PTEN mutations inendometrial carcinomas:A molecular and clinicopathologic analysisof 38 cases,", 31, pp.312~317 (2000)
6. "PTEN,a putative protein tyrosine phosphatasegene mutated in human brain,breast and pro- state cancer.", 275, pp.1943~1947 (1997)
7. "Identification of a candidatetumor suppressor gene 3 that ismutated in multiple advanced cancers.", 15, pp.356~362 (1997)
8. "Germline mutations of the PTEN genein Cowden disease,an inherited breast and thyroid cancer syndrome.", 16, pp.64~67 (1997)
9. "Mutations inthe p53 tumor suppressor gene:clues to cancer etiology and molecularpathogenesis", 54, pp.4855~78 (1994)
10. "The frequencyof p53,K-ras mutations,and microsatellite instability differs in uterineendometrioid and serous carcinoma:evidence of distinct moleculargenetic pathway.", 88, pp.814~824 (2000)
11. "Microsatelliteinstability is uncommon in uterine serous carcinoma.", 150, pp.75~79 (1997)
12. "p53gene mutations are common in uterine serous carcinoma and occurearly in their pathogenesis.", 150, pp.177~185 (1997)
13. "Chromosomal abnormalities andmicrosatellite instability in sporadic endometrial cancer.", 38, pp.1802~1809 (2002)
14. "Microsatellite instability andmutation analysis of candidate genes in unselected sardinian patientswith endometrial carcinoma.", 94, pp.3157~3168 (2002)
15. "Beta-catenin mutations in carcinoma of the uterine endometrium.", 58, pp.3526~3528 (1998)
16. "Mutations ofthe beta-catenin gene in endometrial carcinomas.", 90, pp.55~59 (1999)
17. "Loss of heterozygosity in usualand special variant carcinomas of the endometrium.", 28, pp.607~612 (1997)
18. "PTEN mutation in endometrialcancers is associated with favorable clinical and pathologic characteristics.", 4, pp.3005~3510 (1998)
19. "The tumor suppressor, PTEN", MMAC1, dephosphorylatesthe lipid second messenger, phosphatidylinositol3,4,5-triphosphate., 1998, pp.273, 13375~13378
20. "PTEN,the tumor suppressorfrom human chromosome 10q23,is a dual-specificity phosphatase", 94, pp.9052~9057 (1997)
21. "The multiple roles of PTEN in tumorsuppression.", 100, pp.387~390 (2000)
22. "PTEN", MMAC1mutations and EGFR amplification in glioblastoma,, 1997, pp.57, 5254~5257
23. "Novel germline mutations inthe PTEN tumor suppressor gene found in women with multiplecancers.", 37, pp.336~341 (2000)
24. "Frequent PTEN", MMACmutations in endometrioid but not serous or mucinous epithelialovarian tumors., 1998, pp.58, 2095~2097
25. "Loss of heterozygosity on 10q23.3and mutation of the tumor suppressor gene PTEN in benign endometrialcyst of the ovary:possible sequence progression from benignendometrial cyst to endometrioid carcinoma and clear cell carcinomaof the ovary.", 60, pp.7052~7056 (2000)
26. "PTEN mutation locatedonly outside exons 5,6,and 7 is an independent predictor of favorablesurvival in endometrial carcinomas.", 7, pp.2636~2642 (2001)
27. "Loss ofPTEN expression is associated with metastatic disease in patientswith endometrial carcinoma.", 94, pp.2185~2191 (2002)
28. "PTEN expression is associatedwith prognosis for patients with advanced endometrial carcinomaundergoing postoperative chemotherapy.", 100, pp.686~689 (2002)
29. "p53 function and dysfunction", 70, pp.523~6 (1992)
30. "Direct sequencingof the p53 gene shows absence of mutations in endometrioidendometrial adenocarcinomas expressing p53 protein.", 33, pp.440~445 (1998)

관련 논문AI추천